
METRIC MEDICAL DEVICES, INC.
OperatingMetric Medical Devices, Inc.
Healthcare · Helotes, TX · Founded 2009
Innovative minimally invasive products and technologies for the orthopedic extremity market
Financials
FY2020–FY2022 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inBlue bars are the pre-money valuation the company stated for a priced round.
Share price over rounds
Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.
Fundraising history
Team
34 people
William Casey Fox, Ph.D., P.E. Dr. Fox conducted pioneering research in bone healing and osteoporosis while at Southwest Research Institute, The University of Texas Health Science Center at San Antonio, and the Texas Biomedical Research Institute and made this a foundational element in two of the companies he founded, BioMedical Enterprises, Inc. (BME) and Agile Manufacturing, Inc. Building products and infrastructure with contract service and Federal, State, and County grant revenue he lead BME in the introduction and establishment of the U.S. market for shape-changing bone-compressing nitinol staples. This success resulted in the sale of BME to Depuy/Synthes, Johnson & Johnson Companies. A prolific inventor he has had over 35 patents issued in the U.S. and Europe and published tens of articles. Skilled at medical product development, he and his teams have received 20 FDA clearances to market and commercialized the orthopaedic products stemming from his inventions. He has held engineering, advisory board, and adjunct faculty positions over the last 30 years at the institutions listed above as well as the University of Texas at Austin and the University of Alabama, Birmingham. Dr. Fox founded and leads Metric Medical Devices, Inc. to broaden and advance the shape-changing bone-compressing orthopaedic implants he pioneered at BME. These next-generation nitinol staples and finger and toe fixation implants enter the market Dr. Fox established. These products are being followed by a disruptive minimally invasive external bone fixator based on these same implant shape-changing concepts. This LINK™ External Fixator will allow bone fixation and compression without open surgery. This is a disruptive concept in bone fixation and may, due to its minimally invasive technique, allow surgeons to treat more bone fractures in their office versus the hospital. Dr. Fox and his wife Nancy are 37-year residents of San Antonio and native Texans. During his career, he was recognized in 1998 as Ernst & Young’s Entrepreneur of the Year and in 2005 as a Star of Innovation by the San Antonio community. In 2018 he was honored by the University of Texas at Austin’s Cockrell School of Engineering with the highest honor it bestows on its alumni, the Distinguished Alumni Award, and in 2019 he was inducted into the Department of Mechanical Engineering’s Academy of Distinguished Alumni. Dr. Fox is a registered Professional Engineer in the State of Texas and has spent his entire career focused on the orthopaedic problem and entrepreneurism.

Nancy R. Fox Chief Financial Officer Ms. Fox, co-founder, has over 30 years in the medical device industry. She has received awards and a BBA in Accounting at the University of Texas at San Antonio and focuses on operations including managing production, facilities, inventory, shipping/receiving, customer service and human resources. During her almost two decades as CFO of BioMedical Enterprises, Inc. she managed ISO/GMP quality systems, US and International medical product distribution, obtaining the CE mark and managed FDA, ISO and UL systems & audits.

Mr. Erdner has more than 30 years of experience in the orthopedic industry, leading young companies to become respected competitors in their market. He has refined and managed every aspect of sales, marketing and education. His previous work includes BioPro,Inc., where he conceived and developed a national surgical sales distribution network along with a global international presence in six continents. His professional affiliations include past Chairman of the American Academy of Orthopedic Surgeons Advisory Council, where he was awarded the first Honorable Service Award bestowed by the Academy, and is a past member of the American College of Foot and Ankle Surgeons IAC Advisory Council.

Providing surgical and non-surgical management of foot and ankle disorders, Dr. Albert D’Angelantonio, III, DPM, FACFAS sees adults and adolescents (age 12 and up). Conditions managed include foot and ankle sports injuries, trauma, fractures and sprains, tendonitis, cartilage injuries, skin disorders, heel pain, ganglion cysts, flat feet and arch disorders, arthritis, hammertoes, gait and walking disorders, foot and ankle deformities, and much more. Dr. D’Angelantonio is an Internationally known expert in Foot and Ankle Surgery. Prior to becoming President and Chief Medical Officer of Integrated Foot and Ankle Specialists, Dr. Albert D’Angelantonio III was at Penn Medicine as Assistant Professor of Surgery in the Division of Plastic and Reconstructive Surgery, where he provided outstanding care from 2012-2022. Dr. D’Angelantonio was the first faculty member at Penn Medicine with dedicated expertise in foot, ankle and lower leg reconstruction, and became Fellowship Director to share his knowledge and extensive experience with trainees. He got his advanced training as the very first fellow to complete a dedicated lower extremity fellowship within the Division of Plastic Surgery of Penn Medicine at the Hospital of the University of Pennsylvania. His training focused on providing patients with both functional and aesthetic outcomes for all conditions of the foot, ankle, and lower leg. Dr. D’Angelantonio actively educates surgeons from around the world each year. In fact, he is THE foot and ankle surgeon to other surgeons and their families. He has been recognized: As one of America's Top Foot and Ankle Surgeons, 2012 - 2021 by the Consumers Research Council of America, By Best Doctors in America, 2012 - 2021, By South Jersey Magazine as Top Doctor, 2017 - 2021, As a Penn Medicine Health Care Hero, 2013 - 2021

Board Certifications and Fellowships and appointments American Board of Podiatric Surgery, Board Certified in Foot & Ankle Surgery Fellow, American College of Foot & Ankle Surgeons Past Director and Founder, TMC and Midwestern University School of Podiatric Medicine Residency Program in Foot and Ankle Surgery. Dr. Dahukey is the Co - Past Director and founder of S.A.L.T (Save a Limb Tucson) program at Tucson Medical Center Director, Sahuaro Research Institute, PLLC Adjunct Associate Professor Midwestern University College of Health Sciences Hospital Affiliations:Tucson Medical Center, St. Mary's Hospital, Tucson, Tucson Surgery Center, Northwest Hospital, Tucson Education BA, Boston University, Boston MASS BJ Ed Hebrew College Boston Mass DPM, Kent State University College of Podiatric Medicine, Kent OH, Residency, Veterans Affairs Medical Center, Tucson AZ, Professional Memberships Fellow, American College of Foot and Ankle Surgeons Diplomate, American Board of Foot and Ankle Surgery Personal and professional interests Dr. Amram Dahukey is the founder and chairman of Premier Foot & Ankle Surgeons. He was born in Jerusalem, Israel. Following completion of his medical education, he attended many post graduate courses and received certification in laser surgery, Ankle Arthroscopy and Endoscopic Surgery. Dr. Dahukey has been awarded Master Surgeon for HyProCure procedure for flat feet, a minimally invasive procedure for correction of flat foot deformity. Dr. Dahukey is the founder and Past Director of Tucson Medical Center and Midwestern University Podiatric Residency Program, a three year training program in Foot and Ankle Surgery currently trianing nine residents in foot and ankle surgery. He is also the past Director of Save a Limb Tucson (S.A.L.T) program at Tucson Medical Center. Dr. Dahukey is past President of the Arizona Podiatric Medical Association. He is past chairman of the section of Podiatric Surgery at St. Mary’s Hospital, and Tucson Medical Center. Dr. Dahukey is past secretary-treasurer of Arizona State Physician Association. He currently serves on The Pima County Medical Society Board of Directors. Dr. Dahukeys professional interests include reconstructive foot and ankle surgery, ankle arthroscopy, joint replacement, preventive surgical intervention for diabetic wounds, laser surgery, ingrown toenail, bunion and hammertoe surgery. Dr. Dahukey has been in private practice in Southern Arizona for over 30 years. He is married with two children.

Mr. Hauser has over 24 years experience in the medical device arena specializing in Foot & Ankle Orthopedics, Hand and Wrist, Podiatry, Plastics/Reconstruction, and Sports Medicine. Previous work positions include National Sales Manager for Avanta Orthopedics, Regional Sales Manager for Small Bone Innovations, and Regional Sales Manager for BioMedical Enterprises, Inc. with current co-founders. He also has a Masters in Immunology, which supported his 10+ years of Biological, Immunological, Neurological, and Cardiologic research and multiple publications.

Dr. Christopher Bromley his Doctorate in Podiatric Medicine from the Ohio College Of Podiatric Medicine in Cleveland Ohio. Dr. Bromley graduated with honors and received the Henry Haber Award for Clinical Excellence. He completed his residency program in Podiatric Medicine and Surgery in Baltimore Md, at University of Maryland and Johns Hopkins teaching hospitals. Dr. Bromley is Board Certified in Foot Surgery by the American Board of Podiatric Surgery and is a Fellow of the American College of Foot and Ankle Surgeons. He served as the Chief of Podiatric Medicine at Vassar Brothers Hospital from 2005- 2021 and is a former Director of the St. Francis Hospital Wound Care Center. Dr. Bromley is an international noted expert in Wound Care and Regenerative Medicine and has authored numerous publications. Dr. Bromley currently practices Podiatric Medicine and Surgery in Delray Beach, FL.
Show 25 more peopleShow fewer

Dr. Christopher E. Gross completed a fellowship at Duke University Medical Center in Foot and Ankle Orthopaedic Surgery after completing his residency training at Rush University Medical Center in Chicago. He graduated from Harvard Medical School.As an orthopaedic foot and ankle surgeon, Dr. Gross is particularly interested in complex reconstruction about the ankle in addition to cartilage injuries that range from small defects to end-stage ankle arthritis. He is also keenly interested in Achilles and other sports-related injuries. He is currently developing a multidisciplinary research division by harnessing the power of biologics and improved implant design, and drug delivery systems. He is the author of over 70 published journal articles, over 30 text book chapters

Education & Fellowships Residency - St Vincent Charity Hospital Cleveland, OH USA 2015 Medical Education - Ohio College of Podiatric Medicine (Kent State College of PM) Independence, OH USA 2012 Certifications Foot and Ankle Surgery - Foot Surgery Foot and Ankle Surgery - Reconstructive Rearfoot and Ankle Surgery

R&D and Product Development Engineer Dana Mecke has over 10 years of R&D and product development experience in the medical device industry. She holds a M.S. in biomedical engineering from the University of Texas Health Science Center and a B.S. in mechanical engineering from the University of Texas at San Antonio.

Dr. Daniel Scott is an orthopaedic foot and ankle surgeon at the Medical University of South Carolina. Dr. Scott has extensive experience in total ankle replacements, sports injuries in athletes, post-traumatic reconstruction, fracture care, and complex deformity correction as well as advanced minimally invasive and joint preserving treatment options.As a native of the Carolinas, Dr. Scott graduated with a combined M.D. and MBA degree from Duke University, and went on to complete an orthopaedic surgery residency at Duke University Medical Center. Following this, he completed a fellowship in Foot and Ankle Surgery at Baylor University Medical Center in Dallas, Texas. While at Duke, he was a resident team physician for Duke University athletics, as well as North Carolina Central and Northern High School.Throughout his training, Dr. Scott has received numerous awards for leadership and research. He has been published in a many nationally renowned peer-reviewed journals and has been selected as a reviewer for multiple journals. His work has been presented at numerous local, regional, national, and international meetings.

Education: Des Moines University DPM, Podiatry University of Northern Iowa BS, Biology, Chemistry Training: Reconstructive Rearfoot and Ankle Fellowship, West Houston Medical Center, Foot and Ankle Surgical Residency, West Houston Medical Center Dr. Chaney earned his Doctor of Podiatric Medicine (DPM) degree at Des Moines University. He then completed a two-year foot and ankle surgical residency at the West Houston Medical Center in Houston Texas. Dr. Chaney finished his training in Houston by completing a one-year reconstructive Rearfoot and Ankle Fellowship. Dr. Chaney is board certified in both foot surgery and reconstructive rearfoot and ankle surgery by the American Board of Foot & Ankle Surgery. He has authored numerous papers regarding foot and ankle surgery. He also regularly speaks at regional and national scientific meetings on foot and ankle surgery. Dr. Chaney has served on numerous committees for the American College of Foot & Ankle Surgeons and the American Board of Foot & Ankle Surgery. Dr. Chaney is involved in residency training as clinical adjunct faculty for the University of Texas Health Science Center at San Antonio. He specializes in surgical and non-surgical care of all aspects of foot and ankle care including deformity, injuries, sports medicine, diabetes, wound care, dermatology, arthritis and trauma. Dr. Chaney also specializes 3D Correction for the surgical correction of bunions. This method uses cutting-edge medical instrumentation and fixation to correct your bunion and significantly reducing your likelihood of a recurring bunion.

EDUCATION: 1978-1980 University of Tennessee, Knoxville, Tennessee 1980-1982 The Ohio State University, Bachelor of Science, Columbus, Ohio 1982-1986 Ohio College of Podiatric Medicine, Doctor of Podiatric Medicine, Cleveland, Ohio 1987-1988 California College of Podiatric Medicine, Master of Science , University of Southern California, Los Angeles, California CLINICAL TRAINING: 1987-1988 1st Year Podiatric Residency, Circle City Hospital, Corona, California, Robert Parker, DPM 1988-1989 Advanced Ankle Surgery & Sports Medicine, Fellowship, Hayward Foot and Ankle Clinic, Hayward, California, Steven I. Subotnick, DPM, MS 1989-1990 2nd Year Podiatric ResidencyMedical Center Hospital, Portland, Oregon, John Mozena, DPM, Residency Director BOARD CERTIFIED: 1997 The American Board of Foot and Ankle Surgery, American Council of Certified, Podiatric Physicians and Surgeons LICENSURE: The State of Ohio The State of South Carolina The State of California (Inactive) EMPLOYMENT: Palmetto State Surgical Podiatry Associates

Gary Frashier is President and Principal of Management Associates, a life sciences consulting group, and brings extensive experience in Life science management, operations and transactions having served as a CEO for twenty-four years in life sciences and specialty chemicals. Prior to the founding of Management Associates, a life science consulting group, Dr. Frashier served as Chief Executive Officer and Chairman of OSI Pharmaceuticals, and it was during his tenure at OSI that the leading genetic-based cancer drug, “Tarceva” was discovered and developed thru human Proof of Concept clinical trials. Tarceva is now sold by Roche and Genentech, with combined total sales of over $15 billion, and with continuing expansion into new cancer areas. OSI was acquired by Astellas Pharma in for $4 billion. He has also been involved in the development and commercialization of two other successful major drugs, one for acute asthma (Zolaire) and the other for relief of Parkinson’s disease. Dr. Frashier has raised over $500 million from a combination of equity financings, and other sources, and has organized many collaborations and joint programs with major pharmaceutical companies. Prior to OSI, Dr. Frashier served as President, International, and Executive Vice President of Millipore Corporation; President and CEO of Waters Corporation, the leader in liquid chromatography; President of Loctite Corporation’s Americas Group; and CEO of Genex Corporation, a protein engineering company, and Continental Water Systems, Inc. He has participated as a founder of Merrimack Pharmaceuticals, Inc (NASDAQ); Eutropics, Inc; America Stem Cells, Inc; Apex BioVentures Acquisition Corporation; LikeMinds, Inc.; and Xeras, Inc. He currently serves on the boards of several life science companies, including: LikeMinds, Inc., a private radiochemistry imaging company; Xeras, Inc., a private medical device company with products for improving the outcomes of knee replacement surgery; Metric Medical Devices, Inc, a developer and marketer of orthopedic fixation devices. Dr. Frashier has previously served on the Boards of numerous other private and public life science companies, including Maxim Pharmaceuticals, Inex Pharmaceuticals (Canada), Tanox, Inc., Cytoclonal Pharmaceuticals Co.; Exegenics Pharmaceuticals. Inc.; and Aderis, Inc. He is also a Strategic Partner in two of SV Venture funds. He was one of the founders of the New York Biotechnology Association and was selected as the “Long Island Businessman of the Year” by the Wharton Club. Dr. Frashier is an Advisory Trustee of the Southwest Research Institute, and he is chairman of the Chemical Engineering Advisory Board at the University of Texas at San Antonio, and serves on the Board of BioMed SA. He was recognized by Texas Tech University as a Distinguished Engineer, where he received a B.S. in chemical engineering, and by the Massachusetts Institute of Technology as an Alfred P. Sloan Fellow, where he earned an MBA. He also earned a Ph.D. in innovation leadership from Our Lady of the Lake University. Dr. Frashier is a Registered Professional Engineer in Texas, and he previously served as a First Lieutenant in the U. S. Army Chemical Corps.

Dr. James Walter Simmons, III, serves as President of the South Texas Spinal Clinic and as one of its Partner and Staff Physicians. He holds Clinical Associate Professor appointments at The University of Texas Health Science Center at San Antonio and Baylor College of Medicine. Dr. Simmons is licensed in Texas, Board Certified by the American Board of Orthopaedic Surgeons and specializes in the treatment of congenital and adult deformity of the spine. In addition to his business leadership as President of his practice group, he founded Trinity Medical, Inc. a topical analgesic technology company and served as Medical Director of and on the Board of Directors of BioMedical Enterprises, Inc. Dr. Simmons was deployed with the 5501st U.S.Army Hospital as a surgeon during the Iraq War and honorably discharged with the rank of Major after eleven years of service. He earned his Bachelor of Science in Biology at the University of Texas at San Antonio, Doctorate in Biochemistry at the University of North Texas, Doctorate of Osteopathy from the Texas College of Osteopathic Medicine, and Masters of Business Administration from the McCombs School of Business, University of Texas at Austin. His Internship and Residence were at The University of Texas Medical Branch in Galveston, Texas and Spine Surgery Fellowship at the Twin Cities Spine Center, Minneapolis, Minnesota. Dr. Simmons has received awards for teaching and research, holds membership in multiple professional societies, and has numerous published works and lectures. Dr. Simmons brings to Metric’s Board of Directors personal experience with the changing healthcare landscape, the physician’s perspective, and strong business acumen.

Dr. Enrique L. Rosario Aloma received his Bachelor of Arts in Chemistry with a concentration in Biochemistry and a minor in both Physics and Biology from Florida International University. He then attended Georgetown University where he received his Doctor of Philosophy in Molecular Biology. He started his teaching career at Nova Southeastern University as an Adjunct Professor of Genetics. He completed his Doctor of Podiatric Medicine degree from Barry University and performed his postgraduate work through Barry University’s Mercy Hospital Foot and Ankle Residency Program where he served as resident physician and chief resident. Dr. Rosario Aloma started working at Barry University School of Podiatric Medicine as Adjunct Professor of Immunology and Microbiology. He is now Assistant Professor at the Barry University School of Podiatric Medicine, Foot and Ankle Institute. He has been published multiple times in Podiatry Institute. His current research, in collaboration with colleague Dr. Luis Rodriguez, is in the field of regenerative medicine and stem cell therapies.

Born and raised in Kansas, Dr. Sills-Powell made a decision to pursue his dream of being a doctor. He attended Barry University's School of Podiatric Medicine and Surgery where he earned his degree in Podiatric Medicine (D.P.M.). He then attended a 3-year surgical residency at SSM DePaul Health Center, located in Bridgeton, Missouri. During his surgical residency, Dr. Sills-Powell received advanced training in forefoot, rear-foot, and ankle surgery, with core rotations through all of the primary departments of the hospital. Dr. Sills-Powell treats all medical and surgical conditions of the foot and ankle. He has a special interest in wound management, limb salvage and preservation, trauma, and reconstructive foot and ankle surgery. He is a member in good standing with the APMA (American Podiatric Medical Association) and the APPMA (American Podiatric Practice Management Association). More Than Just Podiatry is also a member of the Western St. Charles County Chamber of Commerce.

Jason M Sweeley, DPM is a board certified by the American College of Foot and Ankle Surgeons. He earned his Bachelor of Science degree in Biology from Lycoming College in Williamsport, PA where he graduated Magna Cum Laude. He completed his Doctor of Podiatric Medicine degree at Temple University School of Podiatric Medicine in Philadelphia, PA. Following graduation, Dr. Sweeley completed 3 years of residency training with Pinnacle Health System in Harrisburg, PA where he underwent extensive training in foot and ankle surgery with an emphasis on reconstructive surgery and diabetic limb salvage. He had the distinction of serving as Chief Resident for the 3 years of his residency training. Dr. Sweeley has advanced training in reconstructive foot and ankle surgery as well as diabetic limb salvage along with training in biomechanical issues and sports medicine. He has completed a micro-vascular surgery course at the Cleveland Clinic and incorporates this training into his surgical approach to neurosurgery including tarsal tunnel decompression. His primary clinical interests include podiatric sports medicine, tarsal tunnel decompression, and rearfoot pathology. His treatment philosophy combines surgical approaches with conservative and non-surgical strategies to restore foot and ankle health and function in both children and adults. Dr. Sweeley is a Fellow of the American College of Foot and Ankle Surgeons and a member of the American Podiatric Medical Association and the Pennsylvania Podiatric Medical Association.

Dr. Miller served as Chief Resident and was recognized for assisting in pioneering the foot and ankle program at the 700+ bed Level 1 trauma center in Philadelphia, PA. Dr. Miller began his career in 2001 teaching in the Department of Surgery at the Temple University School of Podiatric Medicine where he served as Residency Director of the Temple University Health Systems/Northeastern Hospital podiatric residency program and Chief of the section. In 2002, Dr. Miller was honored in the Temple University “Gallery of Success”, an annual prestige that is awarded to a recent and past Temple graduate who has excelled in their chosen career. Dr. Miller continues to hold the rank of Associate Professor as an adjunct faculty member in the Dept. of Surgery at TUSPM. He has been chosen as a Top Doc multiple times in Philadelphia and Main Line Today magazines. Dr. Miller has written numerous articles in several peer-reviewed journals, presented many poster abstracts at national meetings, written and edited chapters in board review books and lectures both nationally and internationally on a variety of topics related to foot and ankle surgery. He currently serves on the editorial board of the Journal of Foot & Ankle Surgery and The Foot and Ankle Journal Online. The PA Intensive Lower Extremity Fellowship program was founded by Dr. Miller in 2011 and was recognized by the American College of Foot & Ankle Surgeons as the nation’s first 2 year foot & ankle post-graduate training program. In 2013, he formed a new 3-year residency program at Phoenixville Hospital to serve the community and provide training opportunities for graduating DPM students nationwide.

Jennie Rogers has almost 20 years of experience in Production and Quality in the Medical Device realm. Ms. Rogers also lends expertise within IT, Graphic Design, and Photography. She worked previously with co-founders at Biomedical Enterprises, Inc. as both a Production Technician and Quality Assurance Specialist. She holds a BS Criminal Justice from University of Maine at Augusta.

Medical School: University of Osteopathic Medicine and Health Sciences, Des Moines, IA 1995 Residency: Deaconess Incarnate Word Health System, St. Louis, MO 1997 Board Certified: American Board of Podiatric Surgery since 2000 Dr. Barth is President and Founder of Next Step Foot & Ankle Centers. He is a leader in Advanced Foot and Ankle Surgical Techniques. Dr. Lindsay Barth received his podiatric medical degree at Des Moines College of Podiatric Medicine and Surgery in Des Moines, Iowa. His surgical podiatric residency was completed at Deaconess Hospital in St. Louis, Missouri. President and founder of Next Step Foot & Ankle Centers, Dr. Barth has been practicing podiatric medicine since 1996. He has been board certified by the American Board of Foot and Ankle Surgery since 2000, and is a leader in Advanced Foot and Ankle surgical techniques. Dr. Barth is a member of the Missouri Podiatric Medical Association, Missouri State Insurance Advisory Board, American Board of Foot and Ankle Surgery, and the American Podiatric Medical Association. Dr. Barth also serves as Chairman of the Political Action Committee. Dr. Lindsay Barth performed the 1st Wright INBONE total ankle replacement surgery in September of 2007. He is one of the only physicians to offer total ankle replacement services in the St. Louis metro area. Throughout the Midwest Dr. Barth provides lectures about Podiatric Surgery and Medicine to his peers and students. He is also actively involved in teaching the residents and students at DePaul Hospital. In addition to his position as senior partner of Next Step Foot & Ankle Centers, Dr. Barth has an interest in Walk Healthy Foot Care Products and Medical Spas. Dr. Barth is an accomplished musician and is a frequent attendee of the St. Louis Symphony. In his spare time, you can find Dr. Barth renovating his 19th century historic home in St. Louis, boating, bicycling, hiking, and gardening.

Mr. Grooms co-founded Regeneration Technologies (Nasdaq: RTIX), a publicly-traded company that processes human tissue for allogenic grafts used in orthopedic, oral maxillofacial, urinary, and cardiovascular surgeries. He co-invented the primary value-added technologies that formed the basis of RTIX’s product line. Mr. Grooms also co-founded AxoGen Corporation, and from 2002 to May 2010 he served as Chief Executive Officer. He had been AxoGen Corporation’s Chairman of the Board of Directors since 2002 and then served as AxoGen, Inc.’s Chairman of Board of Directors since 2011. In addition to his executive management experience, he has extensive experience in many areas of med-tech business operations, including R&D, laboratory and manufacturing operations. He has developed state-of-the-art medical processing and manufacturing systems, robotics, and other technological innovations, and has held various leadership positions with LifeNet, Osteotech (Nasdaq:OSTE), and CryoLife (Nasdaq:CRY). Mr. Grooms holds a degree in biology from Old Dominion University.

Dr. Shibuya earned his doctoral degree in podiatric medicine at Temple University School of Podiatric Medicine in Philadelphia and received his Master of Science in Clinical Investigation from the University of Texas Health Science Center at San Antonio’s School of Biomedical Sciences. Dr. Shibuya is a Fellow of the American College of Foot and Ankle Surgery. He was recently appointed Clinical Professor University of Texas Rio Grande Valley, Edinburg Texas and has been affiliated with Texas A&M University System Health Science Center, Baylor Scott & White Medical Center and the Veteran’s Hospital, Temple TX. Board Certification Board Certified in Reconstructive and Rearfoot and Ankle Surgery (ABFAS) Board Certified in Foot Surgery (ABFAS) Professional Activities Editor-in-Chief, Journal of Foot and Ankle Surgery Scientific Chairman, Annual Meeting of the American College of Foot and Ankle Surgeons Member Texas Podiatric Medical Association, Continuing Medical Education Committee Member Faculty, AO North America Member Scientific editor, Weekly@eACFAS Member Part III National Podiatric Board Examination Item Writing Committee Areas of Interest Foot and Ankle Arthritis Care, Diabetes-Related Foot Conditions, Complete Bunion and Hammertoe Correction, General and Complex Fracture Repair, Minimally Invasive Foot and Ankle Surgery Awards 3rd Place Award, The Effect of Cryotherapy Devices in the Post-Operat OPMA 88th Annual Scientific Seminar Resident Paper Finalist competition ACFAS 2012, 2011 Annual Scientific Conference, Manuscript Finalist 2012 - Manuscript, 3rd Place Award, Incidence of Acute Deep Vein Thromb, ACFAS Annual Scientific Conference 2005 - 63rd ACFAS Annual Meeting and Scientific Seminar, Manuscript Finalist

Ms. Mabry received her BBA in Business Administration and Marketing at the University of Texas at San Antonio. She 5 years of experience in the medical device industry and focuses on building the company’s brand image, studying the market trends, and planning communication strategies to the field.

Dr. Philip Ross Jenkins is a Podiatry Specialist in Lenoir, North Carolina. He graduated with honors from Kent State University College Of Podiatric Medicine in 1996. Having more than 26 years of diverse experiences, especially in Podiatry. CERTIFICATIONS Foot and Ankle Surgery, Board Certified

Ms. Unser has over 10 years experience in the medical device industry. She worked previously with co-founders at BioMedical Enterprises, Inc. (BME) as Customer Service Manager. She is currently a co-owner of CoinNews Media Group LLC, San Antonio, TX and is a Director of the Board of First National Bank, Seiling, OK. She holds a BS Psychology from OSU, Stillwater, OK and MS Public Administration, OU, Norman, OK.

Mr. Williamson is a graduate of The University of Texas at San Antonio with a B.Sc. in Mechanical Engineering. He has worked in the medical field for over 5 years and currently focuses on the development of medical devices and their systems while managing production logistics.

Sudheer Reddy, M.D., is an orthopaedic surgeon who specializes in the diagnosis and treatment of foot and ankle injuries and conditions, as well as sports related injuries. He joined Shady Grove Orthopaedics in 2017. After receiving his undergraduate degree, Dr. Reddy earned his medical degree at Albany Medical College, in Albany, New York. He was welcomed as a Junior year member into the Alpha Omega Alpha Medical Honor Society. Dr. Reddy then completed a surgical internship and orthopaedic surgery residency at the Hospital of University of Pennsylvania, in Philadelphia, Pennsylvania. After finishing his residency, Dr. Reddy completed advanced fellowship training in orthopaedic sports medicine at the University of California-San Francisco, as well as foot and ankle orthopaedic surgery at the Oakland Bone and Joint Center, in Oakland, California. Dr. Reddy is board-certified by the American Board of Orthopedic Surgery. Additionally, he is a fellow of the American Academy of Orthopaedic Surgeons, and an active member of the American Orthopaedic Foot and Ankle Society. When Dr. Reddy is not seeing patients, he enjoys traveling, reading about history, and playing tennis.

Dr. Thomas Sanders, MD, is an orthopedic foot and ankle specialist certified by the American Board of Orthopaedic Surgery practicing at Orthopaedic Foot & Ankle Center (OFAC) in Falls Church, Virginia. Dr. Sanders specializes in the treatment of ankle arthritis, lower extremity trauma, and fractures of the ankle and foot (calcaneus, talus, and Lisfranc injuries). He also helps patients in the Washington, DC, area with post-traumatic reconstruction, midfoot and forefoot arthritis, flatfoot reconstruction, and bunions/hammertoes. Due to his own sports-related injury, Dr. Sanders has a special interest in minimally invasive and arthroscopic treatments for sports and athletic injuries to the foot and ankle. Dr. Sanders attended the University of Virginia in Charlottesville for his bachelor's degree and then earned his medical degree and completed his residency at Georgetown University in Washington, DC. During his final year of residency, he served as the administrative chief resident and earned the Hugh. H. Hussey award for excellence in teaching by Georgetown University School of Medicine twice. After completing his residency, Dr. Sanders went on to complete a fellowship in foot and ankle surgery/lower extremity trauma and reconstruction at the Florida Orthopaedic Institute in Tampa. He received additional, specialized training for both surgical and non-surgical treatments of foot and ankle injuries and diseases, including total ankle arthroplasty. During both his residency and fellowship, Dr. Sanders treated elite level professional, Olympic and collegiate athletes. Outside of his work at Orthopaedic Foot & Ankle Center, Dr. Sanders is an assistant professor at Georgetown University Medical Center in Washington, DC, and a member of both the American Academy of Orthopaedic Surgeons and American Orthopaedic Foot and Ankle Society.
Names and titles as disclosed on StartEngine, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
Filed 1 of 4 annual reports (FY2022–FY2025)
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 10 filings on EDGAR- Form C-TRMay 8, 20240001665160-24-000817EDGAR
- Form C-ARApr 17, 20240001665160-24-000379EDGAR
- Form C-UMar 23, 20230001665160-23-000464EDGAR
- Form C/AJan 20, 20230001665160-23-000114EDGAR
- Form CNov 21, 20220001665160-22-002943EDGAR
- Form D/ANov 17, 20220001539794-22-000005EDGAR
- Form D/AOct 17, 20220001539794-22-000002EDGAR
- Form DOct 17, 20220001539794-22-000004EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.